Shanghai Conant Optical Co Ltd
HKEX:2276
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
6.04
15.7
|
| Price Target |
|
We'll email you a reminder when the closing price reaches HKD.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Shanghai Conant Optical Co Ltd
Total Liabilities & Equity
Shanghai Conant Optical Co Ltd
Total Liabilities & Equity Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Liabilities & Equity | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
S
|
Shanghai Conant Optical Co Ltd
HKEX:2276
|
Total Liabilities & Equity
¥1.8B
|
CAGR 3-Years
7%
|
CAGR 5-Years
11%
|
CAGR 10-Years
N/A
|
|
|
Shandong Weigao Group Medical Polymer Co Ltd
HKEX:1066
|
Total Liabilities & Equity
¥34.5B
|
CAGR 3-Years
5%
|
CAGR 5-Years
7%
|
CAGR 10-Years
N/A
|
|
|
Autobio Diagnostics Co Ltd
SSE:603658
|
Total Liabilities & Equity
¥11B
|
CAGR 3-Years
9%
|
CAGR 5-Years
30%
|
CAGR 10-Years
N/A
|
|
|
Winner Medical Co Ltd
SZSE:300888
|
Total Liabilities & Equity
¥17.1B
|
CAGR 3-Years
10%
|
CAGR 5-Years
34%
|
CAGR 10-Years
N/A
|
|
|
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
|
Total Liabilities & Equity
¥8.2B
|
CAGR 3-Years
16%
|
CAGR 5-Years
26%
|
CAGR 10-Years
N/A
|
|
|
Intco Medical Technology Co Ltd
SZSE:300677
|
Total Liabilities & Equity
¥31.2B
|
CAGR 3-Years
15%
|
CAGR 5-Years
63%
|
CAGR 10-Years
N/A
|
|
Shanghai Conant Optical Co Ltd
Glance View
Shanghai Conant Optical Co., Ltd. engages in business of manufacturing and sale of resin spectacle lenses. The company is headquartered in Shanghai, Shanghai. The company went IPO on 2021-12-16. The firm produces a variety of resin glasses, including standardized lenses and customized lenses. The firm's products are exported to the United States, Japan, India, Australia, Thailand, Germany, Brazil and other countries and regions.
See Also
What is Shanghai Conant Optical Co Ltd's Total Liabilities & Equity?
Total Liabilities & Equity
1.8B
CNY
Based on the financial report for Dec 31, 2023, Shanghai Conant Optical Co Ltd's Total Liabilities & Equity amounts to 1.8B CNY.
What is Shanghai Conant Optical Co Ltd's Total Liabilities & Equity growth rate?
Total Liabilities & Equity CAGR 5Y
11%
Over the last year, the Total Liabilities & Equity growth was 0%. The average annual Total Liabilities & Equity growth rates for Shanghai Conant Optical Co Ltd have been 7% over the past three years , 11% over the past five years .
You don't have any saved screeners yet
